Clarivate Plc is an information services and analytics company that provides structured information and analytics to support scientific research, innovation protection, and commercialization. Its main products include Web of Science (approximately 30% of revenue), Life Sciences solutions like Cortellis (25%), Derwent products (20%), CompuMark services (15%), and MarkMonitor offerings (10%). The company serves a diverse customer base, including government and academic institutions, life sciences companies, and research and development organizations across various regions. Factors that support its endurance include a strong reliance on intellectual property and research, while potential limitations include competition and the need for continuous innovation in a rapidly evolving market.
—
Clarivate Plc is an information services and analytics company that provides structured information and analytics to support scientific research, innovation protection, and commercialization. Its main products include Web of Science (approximately 30% of revenue), Life Sciences solutions like Cortellis (25%), Derwent products (20%), CompuMark services (15%), and MarkMonitor offerings (10%). The company serves a diverse customer base, including government and academic institutions, life sciences companies, and research and development organizations across various regions. Factors that support its endurance include a strong reliance on intellectual property and research, while potential limitations include competition and the need for continuous innovation in a rapidly evolving market.
—
Daily adjusted close
Clarivate Plc is an information services and analytics company that provides structured information and analytics to support scientific research, innovation protection, and commercialization. Its main products include Web of Science (approximately 30% of revenue), Life Sciences solutions like Cortellis (25%), Derwent products (20%), CompuMark services (15%), and MarkMonitor offerings (10%). The company serves a diverse customer base, including government and academic institutions, life sciences companies, and research and development organizations across various regions. Factors that support its endurance include a strong reliance on intellectual property and research, while potential limitations include competition and the need for continuous innovation in a rapidly evolving market.